Insider · CIK 0002070437
Kelley Boucher
officer
Files at APLS (Apellis Pharmaceuticals, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | UTender of shares Common Stock | -127,804 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Common Stock | +15,073 | - | - | 15,073 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -15,073 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Common Stock | +30,146 | - | - | 30,146 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -30,146 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -22,087 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -45,095 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -30,476 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -30,146 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -32,976 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -67,396 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -45,766 | - | - | 0 | May 14, 2026 |
| Jan 28, 2026 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Common Stock | +30,146 | $0.00 | $0 | 127,804 | Jan 30, 2026 |
| Sep 2, 2025 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Common Stock | +30,476 | $0.00 | $0 | 97,658 | Sep 3, 2025 |
| Sep 2, 2025 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +45,766 | $0.00 | $0 | 45,766 | Sep 3, 2025 |
| Jun 9, 2025 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Common Stock | +45,095 | $0.00 | $0 | 67,182 | Jun 11, 2025 |
| Jun 9, 2025 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +67,396 | $19.39 | $1.3M | 67,396 | Jun 11, 2025 |
| May 28, 2025 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Common Stock | +22,087 | $0.00 | $0 | 22,087 | May 29, 2025 |
| May 28, 2025 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +32,976 | $16.80 | $554k | 32,976 | May 29, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.